DiscoverUnseen Upside: Investments Beyond Their ReturnsS6:E3 AI & Biotech: Accelerating Breakthroughs in Medicine
S6:E3 AI & Biotech: Accelerating Breakthroughs in Medicine

S6:E3 AI & Biotech: Accelerating Breakthroughs in Medicine

Update: 2025-11-18
Share

Description

Venture into the world of AI-driven drug discovery, where new models are making the process faster, safer, and more ethical.

Discover how Axiom’s pioneering technology is helping to eliminate the need for animal model testing, paving the way for more humane and effective drug development. Hear from leaders at Cleveland Clinic and Amplify about how AI is transforming healthcare for patients and providers alike.

Guests include:



  • Stefan Strein, Chief Investment Officer at Cleveland Clinic


  • Brandon White, Co-Founder of Axiom


  • Sunil Dhaliwal, Founder and General Partner at Amplify Partners

Unseen Upside: Investments Beyond Their Returns is developed in partnership with PRX, an award-winning podcast media company.

Cambridge Associates is a global investment firm that works with endowments, foundations, healthcare systems, pension plans, and private clients to implement and manage custom investment portfolios that aim to generate outperformance and maximize their impact on the world. Cambridge Associates delivers a range of portfolio management services, including outsourced CIO, non-discretionary portfolio management, staff extension, and asset class mandates.

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

S6:E3 AI & Biotech: Accelerating Breakthroughs in Medicine

S6:E3 AI & Biotech: Accelerating Breakthroughs in Medicine

Cambridge Associates